Northern Trust Corp G1 Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.2 - $4.98 $51,748 - $117,139	23,522 Added 18.74%	149,035 $339,000
Q1 2024 May 14, 2024	SELL	$2.1 - $4.83 $23 - $53	-11 Reduced 0.01%	125,513 $542,000
Q4 2023 Feb 13, 2024	BUY	$1.12 - $3.73 $29,321 - $97,651	26,180 Added 26.35%	125,524 $382,000
Q3 2023 Nov 13, 2023	SELL	$1.22 - $2.67 $450 - $985	-369 Reduced 0.37%	99,344 $143,000
Q2 2023 Aug 11, 2023	SELL	$2.46 - $3.14 $61,096 - $77,985	-24,836 Reduced 19.94%	99,713 $248,000
Q1 2023 May 15, 2023	BUY	$2.57 - $8.16 $17,455 - $55,422	6,792 Added 5.77%	124,549 $333,000
Q4 2022 Feb 13, 2023	BUY	$5.19 - $13.5 $128,618 - $334,557	24,782 Added 26.65%	117,757 $639,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $5,604 - $18,417	1,084 Added 1.18%	92,975 $1.16 Million
Q2 2022 Aug 12, 2022	SELL	$4.04 - $8.51 $1.21 Million - $2.54 Million	-298,695 Reduced 76.47%	91,891 $454,000
Q1 2022 May 13, 2022	SELL	$7.6 - $11.02 $124,495 - $180,518	-16,381 Reduced 4.03%	390,586 $2.97 Million
Q4 2021 Feb 08, 2022	BUY	$10.16 - $16.17 $10,728 - $17,075	1,056 Added 0.26%	406,967 $4.16 Million
Q3 2021 Nov 15, 2021	SELL	$13.16 - $22.47 $190,306 - $324,938	-14,461 Reduced 3.44%	405,911 $5.45 Million
Q2 2021 Aug 13, 2021	BUY	$19.57 - $26.32 $874,485 - $1.18 Million	44,685 Added 11.89%	420,372 $9.22 Million
Q1 2021 May 12, 2021	SELL	$17.58 - $32.59 $427,651 - $792,784	-24,326 Reduced 6.08%	375,687 $9.04 Million
Q4 2020 Feb 11, 2021	SELL	$10.99 - $20.4 $175,070 - $324,972	-15,930 Reduced 3.83%	400,013 $7.2 Million
Q3 2020 Nov 16, 2020	SELL	$11.55 - $23.75 $183,206 - $376,722	-15,862 Reduced 3.67%	415,943 $4.8 Million
Q2 2020 Aug 14, 2020	BUY	$9.57 - $24.37 $127,386 - $324,389	13,311 Added 3.18%	431,805 $10.5 Million
Q1 2020 May 14, 2020	SELL	$9.07 - $26.32 $12,416 - $36,032	-1,369 Reduced 0.33%	418,494 $4.61 Million
Q4 2019 Feb 14, 2020	BUY	$20.54 - $31.0 $325,620 - $491,443	15,853 Added 3.92%	419,863 $11.1 Million
Q3 2019 Nov 13, 2019	BUY	$22.78 - $40.58 $2.31 Million - $4.12 Million	101,558 Added 33.58%	404,010 $9.2 Million
Q2 2019 Aug 13, 2019	BUY	$16.03 - $31.1 $197,169 - $382,530	12,300 Added 4.24%	302,452 $9.27 Million
Q1 2019 May 13, 2019	BUY	$14.4 - $21.45 $121,996 - $181,724	8,472 Added 3.01%	290,152 $4.82 Million
Q4 2018 Feb 12, 2019	BUY	$16.51 - $51.33 $319,633 - $993,748	19,360 Added 7.38%	281,680 $5.39 Million
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $855,448 - $1.35 Million	19,825 Added 8.18%	262,320 $13.7 Million
Q2 2018 Sep 18, 2018	SELL	$35.06 - $51.17 $60,618 - $88,472	-1,729 Reduced 0.71%	242,495 $10.5 Million
Q2 2018 Aug 14, 2018	BUY	$35.06 - $51.17 $3.08 Million - $4.49 Million	87,787 Added 56.12%	244,224 $10.6 Million
Q1 2018 May 09, 2018	BUY	$19.05 - $41.76 $1.39 Million - $3.05 Million	73,149 Added 87.83%	156,437 $5.8 Million
Q4 2017 Feb 14, 2018	BUY	$19.01 - $26.2 $346,723 - $477,861	18,239 Added 28.04%	83,288 $1.65 Million
Q3 2017 Nov 13, 2017	BUY	$12.53 - $27.12 $815,063 - $1.76 Million	65,049	65,049 $1.62 Million

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account